GlassScriptPhysician profile
Dilip Abraham Thomas
NPI 1689613994
$8,053.93
in general payments reported to CMS, 2019-2025
16 companies · $905 in 2025
The $905 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $193 · 2021: $2,286 · 2022: $2,207 · 2023: $1,082 · 2024: $933 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,919.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $5,054.51 | 2020-2023 | Tepezza |
| Amgen INC. | $1,053.46 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $936.34 | 2019-2025 | Clareon, Rocklatan, Rhopressa |
| Johnson & Johnson Surgical Vision, INC. | $146.65 | 2023 | Tecnis Simplicity |
| Dompe US, INC. | $139.51 | 2023-2025 | Oxervate |
| Genentech USA, INC. | $125.00 | 2022 | |
| Shire North American Group INC | $121.62 | 2019 | |
| Harrow Eye, LLC | $91.26 | 2025 | Vevye, Iheezo |
| Oyster Point Pharma, INC. | $89.06 | 2024-2025 | Tyrvaya |
| Alexion Pharmaceuticals, INC. | $82.45 | 2023 | |
| Sun Pharmaceutical Industries INC. | $72.81 | 2019-2021 | |
| Abbvie INC. | $57.72 | 2025 | |
| Medtronic, INC. | $24.34 | 2021 | |
| Merz Pharmaceuticals, LLC | $20.97 | 2022 | |
| Allergan, INC. | $19.67 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $18.56 | 2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilip Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.